Cancer Research UK

U.K. charity gets breast cancer gene patent

Published in Medical Device Law Weekly, March 7th, 2004

A British medical research charity announced on February 11, 2004, it had secured an Europe-wide patent on a key gene that causes hereditary breast cancer, saying cancer researchers across Europe would have free access to the crucial information.

The move is part of a wider battle between researchers working for publicly funded projects and those in private companies, which want to secure the patents for commercial gain. In the United States, the biotechnology company Myriad Genetics of Salt Lake City, Utah, has patents on the gene.

The idea of patenting genes is contentious and some scientists believe that the stuff of life itself should not be...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Device Law Weekly

Source: Medical Device Law Weekly (2004-03-07)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry